Recent Updates
Recently added Catalysts
IRD

Ocuphire to Present at American Society of Retina Specialists Annual Meeting and OIS Retina Innovation Summit

Key Takeaway: Ocuphire to Present at American Society of Retina Specialists Annual Meeting and OIS Retina Innovation Summit

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+140%
120-day peak, hindsight
Typical move
6.3%
average across 11 past catalysts
Cash runway
~22 mo
Low dilution risk
Lead asset
APX3330
Phase 2 · Diabetic Retinopathy

Full Press Release Details

Ocuphire to Present at American Society of Retina Specialists Annual Meeting and OIS Retina Innovation Summit.
Last updated: Jul 26, 2023